Sign in
CompletedNo phase

A Pathophysiological Study of the Postprandial Human Liver (PLS)

Key facts

Who runs it
Copenhagen University Hospital, Hvidovre
Where
Denmark1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
87 people enrolled
Started
2 Mar 2019
Ended
1 Sept 2025
Type of study
Interventional, 3 groups
Treatments tested
  • Standardised meal
  • Glucagon bolus
Record updated
6 July 2026

Who can take part

Age
18 years to 85 years
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (4)Hide the full registry criteria

Who can take part

  • NAFLD (WP2, WP6):
  • Cirrhosis (WP 3):
  • T2DM and NAFLD (WP7):

Other criteria

  • Healthy participants (WP1 , WP4 , WP5 ):

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Fatty liver disease is a globally widespread disease. The identification of valid biomarkers and targets for potential treatments requires in-depth knowledge about the pathophysiology of the postprandial liver. The study will consist of seven work packages (WP) including blood tests and liver biopsies taken after fasting or ingestion of a standardized meal in: healthy controls (WP 1), patients with NAFLD (WP 2), and patients with cirrhosis (WP 3) ; before and after a standardised meal in healthy controls (WP 4), and before and after glucagon in healthy controls (WP5), patients with NAFLD (WP6), and patients with T2DM and NAFLD (WP7).

The 3 groups in the trial

  • Blood tests and liver biopsies after fasting or ingestion of a standardized mealTreatment being tested

    Participants randomized to the meal group consume, over a period of five minutes, a standardized liquid meal (Nutridrink Standard, 200 mL, 300 kcal, Nutricia). Participants randomized to the fasting group remain fasted for one hour after arrival. A transjugular liver biopsy is then performed at minute 60. Blood samples are obtained throughout the study day.

    Treatment: Standardised meal

  • Blood tests and liver biopsies before and after a standardized mealTreatment being tested

    A transjugular liver biopsy is performed, followed by ingestion of a standardized liquid meal (Nutridrink Standard, 200 mL, 300 kcal, Nutricia; 16% protein, 49% carbohydrate, 35% fat). A second transjugular liver biopsy is then performed 30 minutes after meal ingestion. Blood samples are obtained throughout the study day.

    Treatment: Standardised meal

  • Blood tests and liver biopsies before and after a bolus of glucagonTreatment being tested

    A transjugular liver biopsy is performed, followed by an intravenous bolus of 0.2 mg glucagon. A second transjugular liver biopsy is then performed 30 minutes after meal ingestion. Blood samples are obtained throughout the study day.

    Treatment: Glucagon bolus

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
6 July 2026